A5045834931- Helicobacter pylori-related gastroenterology studies
- Gastroesophageal reflux and treatments
- Eosinophilic Esophagitis
- Esophageal and GI Pathology
- Gastrointestinal motility and disorders
- Gastric Cancer Management and Outcomes
- Esophageal Cancer Research and Treatment
- Gastrointestinal disorders and treatments
- Tracheal and airway disorders
- Dysphagia Assessment and Management
- Veterinary medicine and infectious diseases
- Microscopic Colitis
- Colorectal Cancer Screening and Detection
- Respiratory and Cough-Related Research
- Foreign Body Medical Cases
- Gastrointestinal Bleeding Diagnosis and Treatment
- Potassium and Related Disorders
- Clinical practice guidelines implementation
- Gallbladder and Bile Duct Disorders
- Biliary and Gastrointestinal Fistulas
- Mycobacterium research and diagnosis
- Galectins and Cancer Biology
- Diverticular Disease and Complications
- Celiac Disease Research and Management
- Obstructive Sleep Apnea Research
University of Wisconsin–Madison
2015-2025
Aurora Health Care
2014-2020
AstraZeneca (Poland)
2008-2017
American Gastroenterological Association
2017
Janssen (Belgium)
2017
Allergan (Ireland)
2017
Takeda (United States)
2017
Summit School
2015
Arak University of Medical Sciences
2014
Wisconsin Division of Public Health
2014
<b>Background:</b> Guidelines on the management of <i>Helicobacter pylori</i>, which cover indications for and treatment strategies, were produced in 2000. <b>Aims:</b> To update guidelines at European Helicobacter Study Group (EHSG) Third Maastricht Consensus Conference, with emphasis potential <i>H pylori</i> eradication prevention gastric cancer. <b>Results:</b> Eradication infection is recommended (<i>a</i>) patients gastroduodenal diseases such as peptic ulcer disease low grade gastric,...
Esophageal obstruction due to cancer can produce debilitating dysphagia. Rapid palliation is usually possible with endoscopic placement of a plastic esophageal prosthesis, but this device has high rate complications. A new alternative metal-mesh stent that collapses 3 mm in diameter at then expand up 16 mm.
Accurate diagnosis and effective management of gastro-oesophageal reflux disease (GERD) can be challenging for clinicians other health care professionals.To develop a patient-centred, self-assessment questionnaire to assist professionals in the patients with GERD.Questions from patient-reported GERD instruments, previously documented terms content validity psychometric properties (RDQ, GSRS GIS) data on primary secondary were used formal development diagnostic tool, GerdQ, involving...
Endoscopic insertion of biliary stents is the preferred method palliation for inoperable malignant obstruction; however, migration and clogging are frequent problems with conventional endoprostheses. We sought to determine if expandable metal offer improved compared stents. Sixty-two patients common bile duct lesions were randomized receive polyethylene or Stents placed endoscopically by combined percutaneous-endoscopic route. Early results (< 1 month) similar in both groups. Long-term...
Dyspepsia is a chronic or recurrent pain discomfort centered in the upper abdomen; patients with predominant frequent (more than once week) heartburn acid regurgitation, should be considered to have gastroesophageal reflux disease (GERD) until proven otherwise. Dyspeptic over 55 yr of age, those alarm features undergo prompt esophagogastroduodenoscopy (EGD). In all other patients, there are two approximately equivalent options: (i) test and treat for Helicobacter pylori (H. pylori) using...
Background: Once-in-a-lifetime screening for Barrett esophagus has been proposed patients with gastroesophageal reflux disease (GERD), but there is little evidence of its cost-effectiveness. Objective: 1] To determine the cost-effectiveness high-risk groups and providing surveillance to dysplasia or all 2) compare results no surveillance. Design: A decision analytic model was developed examine only without every 2 5 years. Low- high-grade received 6 3 months, respectively. Data Sources:...
<h3>Objective</h3> The aim of this study was to determine the accuracy diagnosis gastro-oesophageal reflux disease (GORD) by Reflux Disease Questionnaire (RDQ), family practitioners, gastroenterologists and a test esomeprazole therapy. <h3>Methods</h3> This single-blind, single-arm over 3–4 weeks from September 2005 November 2006. Each symptom-based diagnostic assessment made blinded prior diagnoses. Patients were those presenting their practitioner with troublesome upper gastrointestinal...
The relation between Helicobacter pylori infection and nonulcer dyspepsia is uncertain. We tested the hypothesis that curing will relieve symptoms of dyspepsia.
Proton pump inhibitors reduce ulcer recurrence in non-steroidal anti-inflammatory drug (NSAID) users, but their impact at-risk ulcer-free patients using the current spectrum of prescribed agents has not been clearly defined. We assessed esomeprazole for prevention (> or = 60 yr and/or history) taking NSAIDs, including COX-2 inhibitors. Such studies are particularly relevant, given that concerns regarding adverse cardiovascular outcomes among inhibitor users may prompt re-evaluation use.We...
Summary Background : Eradication rates of Helicobacter pylori with standard triple therapy are disappointing, and studies from several countries confirm this poor performance. Aim To assess the eradication rate a new sequential treatment regimen compared conventional for H. infection. Methods One thousand forty‐nine dyspeptic patients were studied prospectively. ‐infected randomized to receive 10‐day [rabeprazole (40 mg daily) plus amoxicillin (1 g twice first 5 days, followed by rabeprazole...
Abstract Helicobacter pylori is the primary cause of peptic ulcer disease and an etiologic agent in development gastric cancer. H. infection curable with regimens multiple antimicrobial agents, resistance a leading treatment failure. The Antimicrobial Resistance Monitoring Program (HARP) prospective, multicenter U.S. network that tracks national prevalence rates resistance. Of 347 clinical isolates collected from December 1998 through 2002, 101 (29.1%) were resistant to one agent, 17 (4.8%)...